Secondary analysis of Multivessel TALENT (1,548 patients, 4,052 lesions with three-vessel disease): operator-assessed device success was 97.4% vs 88.0% by core lab QCA and 83.2% by QCA+angio-FFR; lesions failing QCA success had more 1-year LOCE (12.0% vs 9.1%).
Secondary analysisn = 1,548
Oshima et al. Standardised versus visual assessment of device success after percutaneous coronary intervention